Starpharma Holdings (SPHRY, $0.56) was a top loser over the last three months, falling -2 to $0.56 per share. A.I.dvisor analyzed 836 stocks in the Biotechnology Industry for the 3-month period ending May 21, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend. 520 similar cases when SPHRY's price dropped within three months. In out of those 520 cases, SPHRY's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for SPHRY are